Quest Diagnostics Incorporated (DGX)
Company Info
| ISIN | US74834L1008 |
|---|---|
| CUSIP | 74834L100 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| IPO Date | Dec 17, 1996 |
Highlights
| Market Cap | $18.05B |
|---|---|
| EPS (TTM) | $7.45 |
| PE Ratio | 21.70 |
| PEG Ratio | 1.87 |
| Total Revenue (TTM) | $9.54B |
| Gross Profit (TTM) | $3.08B |
| EBITDA (TTM) | $1.82B |
| Year Range | $121.09 - $162.56 |
| Target Price | $168.85 |
| Short % | 2.38% |
| Short Ratio | 3.53 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: DGX vs. ^SP500TR, DGX vs. SPY, DGX vs. UNH, DGX vs. JNJ, DGX vs. XLF, DGX vs. MDT, DGX vs. ABBV, DGX vs. CRL, DGX vs. GILD, DGX vs. XLU
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Quest Diagnostics Incorporated, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Quest Diagnostics Incorporated had a return of 18.95% year-to-date (YTD) and 22.59% in the last 12 months. Over the past 10 years, Quest Diagnostics Incorporated had an annualized return of 12.25%, outperforming the S&P 500 benchmark which had an annualized return of 11.39%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 18.95% | 25.48% |
| 1 month | 7.75% | 2.14% |
| 6 months | 15.22% | 12.76% |
| 1 year | 22.59% | 33.14% |
| 5 years (annualized) | 11.41% | 13.96% |
| 10 years (annualized) | 12.25% | 11.39% |
Monthly Returns
The table below presents the monthly returns of DGX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -6.36% | -2.76% | 6.58% | 4.40% | 2.74% | -3.59% | 4.52% | 10.31% | -1.10% | 0.22% | 18.95% | ||
| 2023 | -4.66% | -6.82% | 2.25% | -1.40% | -4.44% | 5.96% | -3.31% | -2.74% | -7.33% | 7.38% | 5.48% | 0.47% | -10.05% |
| 2022 | -21.62% | -2.78% | 4.26% | -1.72% | 5.36% | -5.25% | 3.20% | -8.24% | -2.09% | 17.72% | 5.69% | 3.04% | -7.35% |
| 2021 | 8.86% | -10.50% | 11.03% | 3.25% | -0.16% | 0.23% | 7.95% | 7.78% | -4.92% | 1.45% | 1.29% | 16.36% | 47.86% |
| 2020 | 4.15% | -4.17% | -24.29% | 38.18% | 7.42% | -3.65% | 12.03% | -12.46% | 2.92% | 7.21% | 1.51% | -3.88% | 14.11% |
| 2019 | 5.56% | -0.92% | 3.89% | 7.81% | -0.49% | 6.15% | 0.78% | 0.28% | 4.55% | -4.92% | 5.23% | 0.23% | 31.13% |
| 2018 | 7.93% | -2.62% | -2.67% | 1.42% | 5.27% | 3.20% | -1.58% | 2.10% | -1.88% | -12.38% | -5.89% | -5.98% | -13.84% |
| 2017 | 0.51% | 6.01% | 0.77% | 7.95% | 3.09% | 2.20% | -2.17% | 0.04% | -13.58% | 0.63% | 4.99% | 0.03% | 9.16% |
| 2016 | -7.17% | 1.31% | 7.40% | 5.79% | 2.66% | 5.49% | 6.60% | -4.10% | 2.68% | -3.77% | 7.39% | 5.08% | 31.90% |
| 2015 | 6.49% | -1.31% | 9.57% | -6.60% | 5.33% | -3.60% | 2.32% | -8.14% | -9.34% | 11.23% | 0.54% | 4.13% | 8.37% |
| 2014 | -1.38% | 0.95% | 9.28% | -2.91% | 7.08% | -2.00% | 4.68% | 3.45% | -4.00% | 5.15% | 2.92% | 2.68% | 28.05% |
| 2013 | -0.03% | -3.07% | 1.06% | -0.23% | 9.78% | -1.48% | -3.83% | 0.53% | 5.92% | -3.04% | 1.72% | -12.14% | -6.24% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of DGX is 72, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Quest Diagnostics Incorporated provided a 1.84% dividend yield over the last twelve months, with an annual payout of $2.96 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.96 | $2.79 | $3.26 | $2.42 | $2.21 | $2.12 | $1.95 | $1.80 | $1.58 | $1.47 | $1.29 | $1.20 |
Dividend yield | 1.84% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% | 2.24% |
Monthly Dividends
The table displays the monthly dividend distributions for Quest Diagnostics Incorporated. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.71 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $0.00 | $0.75 | $0.00 | $2.96 | |
| 2023 | $0.66 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $2.79 |
| 2022 | $0.62 | $0.00 | $0.00 | $0.66 | $0.00 | $0.66 | $0.66 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $3.26 |
| 2021 | $0.56 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $2.42 |
| 2020 | $0.53 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $2.21 |
| 2019 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $0.53 | $0.00 | $0.00 | $2.12 |
| 2018 | $0.45 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $1.95 |
| 2017 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $1.80 |
| 2016 | $0.38 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.40 | $0.00 | $0.00 | $0.00 | $1.58 |
| 2015 | $0.33 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $1.47 |
| 2014 | $0.30 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $1.29 |
| 2013 | $0.30 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $1.20 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Quest Diagnostics Incorporated. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Quest Diagnostics Incorporated was 49.46%, occurring on Feb 14, 2003. Recovery took 452 trading sessions.
The current Quest Diagnostics Incorporated drawdown is 0.88%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -49.46% | May 6, 2002 | 198 | Feb 14, 2003 | 452 | Dec 1, 2004 | 650 |
| -44.75% | Dec 29, 2000 | 57 | Mar 22, 2001 | 63 | Jun 21, 2001 | 120 |
| -36.6% | Mar 6, 2020 | 21 | Apr 3, 2020 | 15 | Apr 27, 2020 | 36 |
| -36.26% | Sep 1, 2006 | 536 | Oct 17, 2008 | 870 | Apr 2, 2012 | 1406 |
| -36.24% | Jun 10, 1998 | 85 | Oct 8, 1998 | 127 | Apr 13, 1999 | 212 |
Volatility
Volatility Chart
The current Quest Diagnostics Incorporated volatility is 7.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Quest Diagnostics Incorporated compared to its peers in the Diagnostics & Research industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for DGX in comparison to other companies of the Diagnostics & Research industry. Currently, DGX has a PE value of 21.7. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for DGX in comparison to other companies of the Diagnostics & Research industry. Currently, DGX has a PEG value of 1.9. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Quest Diagnostics Incorporated.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |